Source: www.cardiosmart.org The "2013 AHA/ACC Guideline on Lifestyle Management to Reduce Cardiovascular Risk" provides recommendations for heart-healthy lifestyle choices based on the latest research and evidence
A 2022 analysis published in Diabetes, Obesity and Metabolism found that semaglutide treatment was associated with significant improvements in patient-reported energy levels and physical functioning scores, with improvements correlating with both weight loss magnitude and reductions in inflammatory markers (Wilding et al., Diabetes, Obesity and Metabolism, 2022, What GLP-1 Medications Cannot Do for Fatigue This is worth addressing directly, because theres a real risk of patients attributing all their fatigue to weight and expecting GLP-1 medications to fix everything
Consistency matters more than occasional high doses for achieving skin brightening and antioxidant benefits
It is also worth noting that night sweats could indicate an unrelated medical condition requiring investigation, such as infection, hormonal imbalance (including menopause or perimenopause), hyperthyroidism, or other metabolic disorders